Morgan Stanley Maintains Overweight, $36 Target on Oracle


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Morgan Stanley reiterates its Overweight rating and $36 target price on Oracle (NASDAQ: ORCL) as the company sees a myriad of catalysts in CY12. Morgan Stanley says, “While we expect Q2 to be solid, our positive thesis on ORCL is about several CY12 drivers including a) a firm apps cycle converging with the Fusion Apps catalyst, b) an improving middleware & analytics story, c) hardware accelerating to 10%+ growth on Exa-family strength and d) margins expanding faster than people expect.” ORCL closed at $29.87 per share on Wednesday.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst ColorReiterationAnalyst RatingsMorgan Stanley